Literature DB >> 32428218

Bilateral retinal detachment after chimeric antigen receptor T-cell therapy.

Christopher C Denton1,2, William S Gange3,4, Hisham Abdel-Azim1,2, Sonata Jodele1,5, Neena Kapoor1,2, Matthew J Oberley6, Kenneth Wong1,7, Jonathan Kim3,4, Abby Vercio8, Parisah Moghaddampour8, K V Chalam8, David Sierpina8, Rebecca A Gardner9,10, Michael A Pulsipher1,2, Michael C Jensen9, Aaron Nagiel3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32428218      PMCID： PMC7252550          DOI： 10.1182/bloodadvances.2020001450

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  20 in total

1.  Role of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Predicting the Adverse Effects of Chimeric Antigen Receptor T Cell Therapy in Patients with Non-Hodgkin Lymphoma.

Authors:  Jiasheng Wang; Yongxian Hu; Shuye Yang; Guoqin Wei; Xin Zhao; Wenjun Wu; Yanlei Zhang; Yafei Zhang; Donghe Chen; Zhao Wu; Lei Xiao; Alex Hongsheng Chang; He Huang; Kui Zhao
Journal:  Biol Blood Marrow Transplant       Date:  2019-02-12       Impact factor: 5.742

Review 2.  Interleukin-6 as a therapeutic target.

Authors:  Jean-François Rossi; Zhao-Yang Lu; Michel Jourdan; Bernard Klein
Journal:  Clin Cancer Res       Date:  2015-01-14       Impact factor: 12.531

3.  Cataract formation and other complications of intravitreal triamcinolone for macular edema.

Authors:  John T Thompson
Journal:  Am J Ophthalmol       Date:  2006-04       Impact factor: 5.258

Review 4.  Recent advances in CAR T-cell toxicity: Mechanisms, manifestations and management.

Authors:  Jennifer N Brudno; James N Kochenderfer
Journal:  Blood Rev       Date:  2018-11-14       Impact factor: 8.250

5.  Intraocular relapse of childhood acute lymphoblastic leukaemia.

Authors:  Tim C P Somervaille; Ian M Hann; Georgina Harrison; Tim O B Eden; Brenda E Gibson; Frank G Hill; Chris Mitchell; Sally E Kinsey; Ajay J Vora; John S Lilleyman
Journal:  Br J Haematol       Date:  2003-04       Impact factor: 6.998

6.  Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.

Authors:  Shannon L Maude; Theodore W Laetsch; Jochen Buechner; Susana Rives; Michael Boyer; Henrique Bittencourt; Peter Bader; Michael R Verneris; Heather E Stefanski; Gary D Myers; Muna Qayed; Barbara De Moerloose; Hidefumi Hiramatsu; Krysta Schlis; Kara L Davis; Paul L Martin; Eneida R Nemecek; Gregory A Yanik; Christina Peters; Andre Baruchel; Nicolas Boissel; Francoise Mechinaud; Adriana Balduzzi; Joerg Krueger; Carl H June; Bruce L Levine; Patricia Wood; Tetiana Taran; Mimi Leung; Karen T Mueller; Yiyun Zhang; Kapildeb Sen; David Lebwohl; Michael A Pulsipher; Stephan A Grupp
Journal:  N Engl J Med       Date:  2018-02-01       Impact factor: 91.245

7.  LEUKEMIC OPTIC NERVE INFILTRATION IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA.

Authors:  Manish P Nagpal; Navneet S Mehrotra; Rajen C Mehta; Chaitanya K Shukla
Journal:  Retin Cases Brief Rep       Date:  2016

Review 8.  Neurotoxicity Associated with CD19-Targeted CAR-T Cell Therapies.

Authors:  Juliane Gust; Agne Taraseviciute; Cameron J Turtle
Journal:  CNS Drugs       Date:  2018-12       Impact factor: 5.749

9.  Tisagenlecleucel Model-Based Cellular Kinetic Analysis of Chimeric Antigen Receptor-T Cells.

Authors:  Andrew M Stein; Stephan A Grupp; John E Levine; Theodore W Laetsch; Michael A Pulsipher; Michael W Boyer; Keith J August; Bruce L Levine; Lori Tomassian; Sweta Shah; Mimi Leung; Pai-Hsi Huang; Rakesh Awasthi; Karen Thudium Mueller; Patricia A Wood; Carl H June
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2019-03-07

10.  Rapidly Progressive, Isolated Subretinal Leukemic Relapse: A Case Report.

Authors:  Thomas B Gillette; Michelle T Cabrera; Katherine Tarlock; Claire E Murphy; Karen M Chisholm; Andrew W Stacey
Journal:  Ocul Oncol Pathol       Date:  2017-12-22
View more
  7 in total

Review 1.  Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion.

Authors:  Leila Amini; Sara K Silbert; Nirali N Shah; Mohamed Abou-El-Enein; Shannon L Maude; Loretta J Nastoupil; Carlos A Ramos; Renier J Brentjens; Craig S Sauter
Journal:  Nat Rev Clin Oncol       Date:  2022-03-22       Impact factor: 66.675

Review 2.  Beyond the storm - subacute toxicities and late effects in children receiving CAR T cells.

Authors:  Haneen Shalabi; Juliane Gust; Agne Taraseviciute; Pamela L Wolters; Allison B Leahy; Carlos Sandi; Theodore W Laetsch; Lori Wiener; Rebecca A Gardner; Veronique Nussenblatt; Joshua A Hill; Kevin J Curran; Timothy S Olson; Colleen Annesley; Hao-Wei Wang; Javed Khan; Marcelo C Pasquini; Christine N Duncan; Stephan A Grupp; Michael A Pulsipher; Nirali N Shah
Journal:  Nat Rev Clin Oncol       Date:  2021-01-25       Impact factor: 66.675

3.  Adjuvant Scrotal Radiation Therapy As Bridging Therapy to Chimeric Antigen Receptor T-Cell Following Extramedullary Relapse in B-Cell Acute Lymphoblastic Leukemia.

Authors:  Colton Ladbury; Amandeep Salhotra; Savita Dandapani
Journal:  Cureus       Date:  2021-12-03

4.  Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapy.

Authors:  Elizabeth M Holland; Bonnie Yates; Alex Ling; Constance M Yuan; Hao-Wei Wang; Maryalice Stetler-Stevenson; Michael LaLoggia; John C Molina; Daniel A Lichtenstein; Daniel W Lee; John A Ligon; Haneen Shalabi; Mark A Ahlman; Nirali N Shah
Journal:  Blood Adv       Date:  2022-04-12

Review 5.  Combination strategies to optimize the efficacy of chimeric antigen receptor T cell therapy in haematological malignancies.

Authors:  Xinyi Xiao; Yazhuo Wang; Zhengbang Zou; Yufei Yang; Xinyu Wang; Xin Xin; Sanfang Tu; Yuhua Li
Journal:  Front Immunol       Date:  2022-08-23       Impact factor: 8.786

Review 6.  Recent findings on chimeric antigen receptor (CAR)-engineered immune cell therapy in solid tumors and hematological malignancies.

Authors:  Ali Keshavarz; Ali Salehi; Setareh Khosravi; Yasaman Shariati; Navid Nasrabadi; Mohammad Saeed Kahrizi; Sairan Maghsoodi; Amirhossein Mardi; Ramyar Azizi; Samira Jamali; Farnoush Fotovat
Journal:  Stem Cell Res Ther       Date:  2022-09-24       Impact factor: 8.079

7.  Leukemia escape in immune desert: intraocular relapse of pediatric pro-B-ALL during systemic control by CD19-CAR T cells.

Authors:  Semjon Willier; Johannes Raedler; Franziska Blaeschke; Dana Stenger; Montserrat Pazos Escudero; Florian Jurgeleit; Thomas G P Grünewald; Vera Binder; Irene Schmid; Michael H Albert; Armin Wolf; Tobias Feuchtinger
Journal:  J Immunother Cancer       Date:  2020-09       Impact factor: 13.751
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.